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The development of reliable, sensitive, and specific serological methods for the detection of human herpesvirus-8 (HHV-8)
antibodies is critical for a thorough understanding of HHV-8 prevalence and pathogenesis. To evaluate the potential
usefulness of HHV-8 proteins in measuring the responses against both latent and lytic antigens, we selected 1 latent [open
reading frame (ORF) 73] antigen and 3 HHV-8 lytic antigens (ORFs 65, K8.1A, and K8.1B) previously identified as immunogenic
[Virology (1998) 243, 208–217]. Full-length genomic ORF 73 and full-length ORFs 65, K8.1A, and K8.1B from the cDNA clones
were cloned, expressed in bacterial and baculovirus-insect cell expression systems, and purified as GST fusion proteins.
These recombinant proteins were used in Western blot reactions to test sera from 104 human immunodeficiency virus
(HIV)1/Kaposi’s sarcoma (KS)1 homosexual men, 77 HIV1/KS2 homosexual men, and 84 age-matched HIV2/KS2 men. These
sera were also tested in immunofluorescence assays (IFAs) with uninduced and 12-O-tetradecanoylphorbol-13-acetate-
induced B cell lymphoma-1 cells to detect antibodies against latency-associated nuclear antigens (LANA) and antibodies
against lytic antigens (cytoplasmic fluorescence). These sera exhibited differential reactivities reflecting different titers of
antibodies against HHV-8 proteins, and variable reactivities were seen more commonly with the sera from HIV2/KS2 adult
men. In the Western blot assay, 89% (93 of 104) of HIV1/KS 1 sera, 60% (46 of 77) of HIV1/KS2 sera, and 7% (6 of 84)
HIV1/KS2 sera were reactive with both latent and lytic recombinant antigens. Western blot reactions with ORF 73 protein
were more sensitive than LANA–IFA results. The lytic IFA and lytic Western blot (ORFs 65 and K8.1A) assays were more
sensitive than the ORF 73 Western blots and LANA–IFA. With an exception of 2 sera from the HIV2/KS2 group, all sera
positive for lytic IFA antibodies and ORF 65 and K8.1A antibodies were also positive for latent antibodies. With few exceptions,
sera positive for ORF 65 antibodies were also positive for K8.1A antibodies, and sera recognized the K8.1A protein more often
than the K8.1B protein. There is a high degree of concordance between IFA and Western blot reactions, suggesting that this
panel of HHV-8 recombinant proteins could detect a majority of the HHV-8-seropositive individuals. These results suggest
that IFA followed by confirmation with the Western blot reactions with a panel of latent and lytic immunogenic antigens would
provide a reliable, sensitive, and specific method for the detection of HHV-8 antibodies. © 1999 Academic PressH
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The newly identified human herpesvirus-8 (HHV-8) or
aposi’s sarcoma (KS)-associated herpesvirus (KSHV) is
trongly associated with KS (Chang et al., 1994, 1996;
chulz et al., 1998), and the outcome of a primary HHV-8
nfection in healthy individuals is not known at present.
HV-8 DNA has been detected in .95% of KS lesions
tudied, both in HIV2 and HIV1 individuals and in all
linical subtypes of KS (Ambroziak et al., 1995; Boshoff et
l., 1995; Chang et al., 1994, 1996; Moore et al., 1995;
chulz et al., 1998; Smith et al., 1997). In addition, HHV-8
equences have been detected in body cavity-based B
ell lymphomas (BCBLs) (Cesarman et al., 1995; Moore
t al., 1996; Renne et al., 1996). The sequence of ;160-kb
1 To whom reprint requests should be addressed. Fax: (913) 588-
295. E-mail: bchandra@kumc.edu.381HV-8 DNA encoding 80 complete ORFs has been pub-
ished recently (Neipel et al., 1997; Russo et al., 1996).
hese HHV-8 ORFs are currently identified as ORFs 1–75
y their similarity to herpesvirus Saimiri (HVS) ORFs.
usso et al. (1996) also identified 15 ORFs unique for
HV-8 designated K1–K15. Neipel et al. (1997) identified
additional HHV-8 unique ORFs and assigned decimal K
umbers for them (K4.1, K4.2, K8.1, and K10.1).
Measurement of serological responses elicited
gainst HHV-8 is critical for the accurate evaluation of
he incidence of HHV-8 infection and for the diagnosis
nd prognosis of HHV-8 infection. Cell lines (BC-1, HBL-6,
nd BCBL-1) have been established from the BCBL tu-
ors (Cesarman et al., 1995; Gao et al., 1996, 1996;
oore et al., 1996; Renne et al., 1996). BC-1 and HBL-6
arry both HHV-8 and Epstein–Barr virus (EBV). BCBL-1
ells carry only HHV-8, and lytic cycles can be induced
y 12-O-tetradecanoylphorbol-13-acetate (TPA) (Chan et0042-6822/99 $30.00
Copyright © 1999 by Academic Press
All rights of reproduction in any form reserved.
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382 ZHU ET AL.l., 1998; Chandran et al., 1998a, 1998b; Renne et al.,
996, Smith et al., 1997). These BCBL cells have been
sed in immunofluorescence assays (IFAs) and Western
lot assays to measure antibody responses in human
era (Chandran et al., 1998a, 1998b; Gao et al., 1996 a
nd b; Kedes et al., 1996; Lennette et al., 1996; Smith et
l., 1997). Nuclear fluorescence detected in uninduced
CBL cells was designated as measuring antibodies
gainst latency-associated nuclear antigens (LANA), and
ytoplasmic fluorescence detected in the induced cells
as designated as measuring antibodies against lytic
ntigens. These studies show that HHV-8 seropreva-
ence in the normal population varies according to the
ountry of origin, reflecting the differences in the inci-
ence of non-AIDS KS. Although there are discrepancies
n the reported incidence of HHV-8 infection in the nor-
al U.S. population (Schulz et al., 1998), these studies
uggest that HHV-8 is not ubiquitous in the United States.
IFA using uninduced and TPA-induced BCBL-1 cells
etects a spectrum of antibodies against a number of
HV-8 proteins. However, it is tedious and subjective. It
lso requires experience in microscopic observation and
s hampered by nonspecific reactions at the lower dilu-
ions of sera. Our studies showed that as in other her-
esviruses, human serological responses were directed
gainst a number of HHV-8-specific proteins and glyco-
roteins. Sera from HIV1/KS1 and HIV1/KS2 individuals
mmunoprecipitated several HHV-8-specific proteins and
lycoproteins (Chandran et al., 1998a). Sera from HIV2/
S2 individuals and from a majority of HIV1/KS2 individ-
als had low titers of HHV-8 antibodies, recognizing only
subset of viral proteins. Hence, to detect the low level
f persisting antibodies, it is critical to identify the immu-
ogenic HHV-8 proteins. Gao et al. (1995b) used the BC-1
ell line (HHV81, EBV1) in Western blot assays and
dentified a 234/226-kDa doublet protein associated with
he nuclei of uninduced cells as an HHV-8-specific laten-
y-associated protein. Rainbow et al. (1997) reported that
he ORF 73 [1162 amino acids (aa)] encoding the 234/
26-kDa protein was responsible for the majority of the
ANA-type reactivities of sera. Studies by Simpson et al.
1996) and Lin et al. (1997) showed that the HHV-8 ORF
5 protein (170 aa) was an immunogenic lytic cycle-
ssociated protein. In these studies, only a single HHV-8
rotein was used to evaluate the serological responses,
nd so far, antibody responses to both latent and lytic
ntigens have not been examined thoroughly in a single
nvestigation.
To identify the immunogenic HHV-8 proteins, we pre-
iously screened a cDNA library from TPA-induced
CBL-1 cells with an HIV1/KS1 serum. We identified
everal cDNAs encoding HHV-8 ORFs 6, 8, 9, 25, 26, 39,
9, 65, 68, 73, K8.1A, and K8.1B. The ORFs K8.1A (228 aa)
nd K8.1B (167 aa) encode HHV-8-specific glycoproteins
Chandran et al., 1998a). Our initial testing of human sera
n the Western blot reactions suggested that measure-ent of anti-ORF K8.1A antibodies would provide an
HV-8-specific serological assay (Chandran et al.,
998a, 1998b). To compare the serological responses
gainst both latent and lytic antigens of HHV-8, we se-
ected the following ORFs as target antigens: ORF 73
dentified as a major immunogenic latent infection pro-
ein (Rainbow et al., 1997), ORF 65 identified as an
mmunogenic lytic cycle-associated protein (Lin et al.,
996; Simpson et al., 1996), and ORFs K8.1A and K8.1B,
mmunogenic proteins unique for HHV-8 (Chandran et
l., 1998a, 1998b; Raab et al., 1998). Full-length ORFs 65,
8.1A, and K8.1 B from the cDNA clones and the full-
ength genomic ORF 73 were cloned and expressed as
ST fusion proteins in bacterial and baculovirus expres-
ion system. These fusion proteins were purified by
lutathione–Sepharose columns. Panels of human sera
rom HIV1/KS1, HIV1/KS2, and HIV2/KS2 individuals
ere tested with these 4 HHV-8 recombinant proteins by
estern blot assays and with uninduced and TPA-
nduced BCBL-1 cells by IFA. Differential responses of
era were detected; the results are presented here.
RESULTS
xpression of ORFs 73, 65, K8.1A, and K8.1B as GST
usion proteins:
To express the fusion proteins in bacteria and bacu-
ovirus, HHV-8 ORFs 73, 65, K8.1A, and K8.1B were cloned
nto the GST-expression vectors, and the fusion proteins
ere purified by passing through glutathione–Sepharose
B. The purity of these proteins was verified by SDS–
AGE, followed by staining with coomassie blue (Figs.
A and 1B). Approximately equal quantities of these
roteins (100 ng) were loaded per lane. The expected
izes of ORFs 73, 65, K8.1A, and K8.1B fusion proteins in
he bacterial system were 185, 52–54, 48–50, and 42–44
Da, respectively. The purified GST protein was ;29 kDa
Figs. 1A and 1B, lane 1). The expected size of 48–50-kDa
ST–ORF 65 fusion protein was detected in the bacteria
Fig. 1A, lane 4) and the baculovirus-infected insect cells
Fig. 1B, lane 2). The observed sizes of ORF K8.1A and
8.1B fusion proteins expressed in the bacteria were
2–54 and 48–50 kDa, respectively (Fig. 1A, lanes 2 and
). The relative sizes of ORF K8.1 A and K8.1B fusion
roteins expressed in the baculovirus-infected insect
ells were slightly higher; this is probably due to post-
ranslational glycosylation in the insect cells (Fig. 1B,
anes 3 and 4). In the bacteria, the size of GST–ORF 73
usion protein was similar to the expected size of ;185
Da with a sharp band appearance (Fig. 1A, lane 5). In
he baculovirus-infected insect cells, a diffused band of
215 kDa was seen (Figs. 1B, lane 5, and 1D, lane 1).
ecause ORF 73 is a phosphoprotein (B. Chandran et al.,
anuscript in preparation), this higher molecular mass is
robably due to post-translational modifications, pre-
umably phosphorylation. Compared with the expres-
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383REACTIVITIES WITH HHV-8 ORFS 73, 65, K8.1A, AND K8.1B PROTEINSions in the bacuolvirus system, the expressions of GST–
RF 73 and –ORF K8.1A in bacteria were unstable. Ad-
itional faintly stained lower-molecular-weight proteins
ere detected more in bacteria than in the insect cells
nd probably represented proteolytic products gener-
ted before and/or during the purification procedures.
To optimize the concentrations of antigens to be used
n the Western blot reactions, we initially tested different
mounts of the affinity purified GST and GST–ORFs 73,
5, K8.1A, and K8.1B fusion proteins with different dilu-
ions of an HIV1/KS1 serum with an HHV-8 lytic antibody
iter of .1:10,240. The concentration of antigens detect-
ng specific HHV-8 antibodies at the highest dilution of
erum was determined, and we used ;100 ng/well of
FIG. 1 Expression of HHV-8 latency and lytic cycle-associated protei
ith baculovirus (Bv). Full-length ORFs 65, K8.1A, and K8.1B were subclo
3 was amplified by PCR and cloned. These were expressed as GST
y glutathione–Sepharose columns. Samples were analyzed on 10% a
arkers run in parallel lanes. The arrows indicate the locations of GST
roteins expressed in the bacteria. Lane 1 indicates GST; lane 2, GST–O
3. (B) Coomassie blue-stained gel showing purified proteins expressed
8.1B; lane 4, GST–ORF K8.1A; and lane 5, GST–ORF 73. (C and D) W
HV-8 proteins and GST control expressed in bacteria (Bt). (C) React
eactivities of an HIV1/KS1 HHV-8 seropositive serum at a dilution of
, GST–ORF K8.1A and K8.1B (Bt); lane 4, GST (Bt). (D) Lane 1 indicates
ST–ORF K8.1A and K8.1B (Bt); and lane 5, GST (Bt).ach antigen for all our subsequent reactions. Typical
eactivities of HHV-8 antibody-positive and -negative
era with the bacterially expressed proteins are shown
n Figs. 1C and 1D. Several HIV1/KS2 sera negative for
HV-8 antibodies in IFA were also negative in the West-
rn blot reactions with the HHV-8 GST–ORF fusion pro-
eins (Fig. 1C, lanes 1–4). In contrast, a serum from an
IV1/KS1 individual recognized the GST–HHV-8 fusion
roteins expressed in bacteria and insect cells (Fig. 1D,
anes 1–4), and no reactivity was seen with the GST
rotein alone (Fig. 1D, lane 5). A diffused band of 215 kDa
f GST–ORF 73 protein from the baculovirus (Bv)-infected
nsect cells (Fig. 1D, lane 1) and a sharp band of 185 kDa
rom bacteria (Bt) (Fig. 1D, lane 2) were recognized by
the recombinant plasmids in bacteria (Bt) and in insect cells infected
m the cDNAs (Chandran et al., 1998a, 1998b). Full-length genomic ORF
proteins in bacteria and baculovirus-infected insect cells and purified
ide gels, and numbers indicate the molecular weights of prestained
ST–HHV-8 proteins. (A) Coomassie blue-stained gel showing purified
.1B; lane 3, GST–ORF 65; lane 4, GST–ORF K8.1A; and lane 5, GST-ORF
c-t cells. Lane 1 indicates GST; lane 2, GST–ORF 65; lane 3, GST–ORF
blot reactions with equal amounts (;100 ng/well) of the recombinant
f an HIV1/KS2 HHV-8 seronegative serum at a dilution of 1:100. (D)
0. (C) Lane 1 indicate GST–ORF 73 (Bt); lane 2, GST–ORF 65 (Bt); lane
RF 73 (Bv); lane 2, GST–ORF 73 (Bt); lane 3, GST–ORF 65 (Bt); lane 4,ns from
ned fro
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384 ZHU ET AL.his serum. This serum also reacted strongly with the
RFs 65, K8.1A, and K8.1B fusion proteins (Fig. 1D, lanes
and 4). The smaller-molecular-weight proteins recog-
ized by the serum probably represented the breakdown
roducts.
ifferential reactivities of human sera with ORFs 73,
5, K8.1A, and K8.1B GST fusion proteins in the
estern blot reactions:
To compare the ability of HHV-8 recombinant antigens
n detecting anti-HHV-8 antibodies, we used sera from
04 HIV1/KS1 homosexual men, 77 HIV1/KS2 homosex-
al men, and 84 age-matched HIV2/KS2 men. These
era were tested at a dilution of 1:100 in the Western
lots with GST alone and GST-fusion proteins. Some of
he positive sera were retested by titration. Coded sera
ere tested in two formats of Western blot reactions.
ne format used membranes containing each antigen
ORFs 73, 65, K8.1A 1 K8.1B, GST) in individual lanes (Fig.
), and the other used single lanes containing a cocktail
f all 5 antigens (Fig. 3). Initially, 50 sera from each of the
FIG. 2. Reactivities of human sera in Western blot reactions with the
mounts of purified GST and GST–HHV-8 fusion proteins expressed in
lotted. Prestained molecular weight markers were run in parallel lanes
A–D) Reactivities of 4 different sera from HIV1/KS1 individuals. (E–G) R
he locations of GST and GST–HHV-8 proteins. (A) Lanes 1–4, ORFs K8
8.1B, 65, and 73, respectively. (C) Lanes 1–5, GST, K8.1B, K8.1A, 65, and
E) Lanes 1–4, 73, 65, K8.1A and K8.1B, and GST, respectively. (F) Lanes
nd K8.1B, 65, and GST, respectivelyhree groups were tested with HHV-8 proteins expressed
n both bacteria and insect cells. Examples are shown in
igs. 2 and 3, respectively. Similar results were observed
y using bacterial or baculovirus-expressed HHV-8 pro-
eins. Most of the sera reacted better with bacuolvirus-
xpressed ORF73 protein (Fig. 3) than with the bacterial
ecombinant protein (Fig. 2). We subsequently used bac-
lovirus-expressed proteins to test the remainder of the
era in the panels; the results are summarized in Table 1.
Sera showed very specific reactivities with the HHV-8
ecombinant proteins expressed in both bacteria and
nsect cells but not with GST alone (Figs. 2 and 3). These
era showed differential reactivities with the HHV-8 pro-
eins and were grouped into four general patterns. In
attern 1, several sera showed strong reactivities with
oth latent (ORF 73) and lytic (ORFs 65, K8.1A, and K8.1B)
roteins (Figs. 2A–2C, 2E, 3A, lanes 1 and 2, 3B, lane 1,
nd 3C, lane 1); 88% (91 of 104) of the HIV1/KS1 sera,
1% (24 of 77) of the HIV1/KS2 sera, and 2.3% (2 of 84) of
IV2/KS2 sera exhibited this pattern. In pattern 2, sera
howed weak reactivities with the ORF 73 protein (latent)
binant HHV-8 proteins and GST control expressed in bacteria. Equal
ia (;100 ng/well) were separated in 10% acrylamide gel and Western
panel (A–G) represents the reactivities of 1 serum at a dilution of 1:100.
ties of 3 different sera from HIV1/KS2 individuals. The arrows indicate
K8.1B, K8.1A, 65, and 73, respectively. (B) Lanes 1–4, GST, K8.1A and
pectively. (D) Lanes 1–4, 73, K8.1A and K8.1B, 65, and GST, respectively.
ST, K8.1A and K8.1B, 65, and 73, respectively. (G) Lanes 1–4, 73, K8.1Arecom
bacter
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385REACTIVITIES WITH HHV-8 ORFS 73, 65, K8.1A, AND K8.1B PROTEINSnd strong reactivities with the lytic (ORFs 65, K8.1A, and
8.1B) proteins (Figs. 3A, lanes 3 and 4, 3B, lanes 2–4,
nd 3C, lane 2); 2% (2 of 104) of the HIV1/KS1 sera, 36%
28 of 77) of the HIV1/KS2 sera, and 7% (6 of 84) of the
IV2/KS2 sera showed this pattern. In pattern 3, there
ere variable reactivities with the latent and lytic anti-
ens (Figs. 2D, 2F, and 2G); 8% (8 of 104) of the HIV1/KS1
era, 5% (4 of 77) of HIV1/KS2 negative sera, and 10% (8
f 84) of the HIV2/KS2 sera showed this pattern. Several
era showed stronger reactivities with the ORF 65 pro-
ein than with the K8.1A and K8.1B proteins (Figs. 2F, 2G,
nd 3C, lane 2). Some sera showed reactivities only with
he ORF K8.1A protein, not with the ORF K8.1B protein.
ther sera were strongly positive with the ORF K8.1A
rotein and weakly positive with the ORF 65 protein.
ost sera reacting with the ORF 65 protein were also
ositive for anti-ORF K8.1A antibodies; however, few sera
ositive for ORF 65 antibodies were negative for K8.1A
ntibodies, and vice versa (Tables 2-4). Variable reactiv-
FIG. 3. Reactivities of human sera in Western blot reactions with the
Bv)-infected insect cells. GST and GST–HHV-8 fusion proteins express
mounts of these five protein samples were mixed, and samples were r
arkers were run in parallel lanes. Each lane represents the reactivit
IV1/KS1 individuals. (B) Reactivities of 4 different sera from HIV1/KS2
rrows indicate the locations of GST and GST–HHV-8 proteins.
T
Reactivities of Human Sera in IFA With BCBL-1 Cells with or witho
Group No. of sera
No. (%) positive by IFAa
LANA Lytic
IV1/KS1 104 87 (84) 103 (99
IV1/KS2 77 43 (56) 58 (78
IV2/KS2 84 7 (8) 10 (12
a Sera were tested at a starting dilution of 1:10 with uninduced and
998a, 1998b). Sera showing specific nuclear fluorescence with unind
nduced cells (lytic) at 1:40 dilutions and above were considered as p
b Sera were tested at a starting dilution of 1:100 with Western blo
aculovirus expression constructs (Fig. 3).ties were seen more commonly with the sera from HIV2/
S2 adult men (Table 4). Three sera showed reactivities
ith the ORF 65 protein but not with the ORF K8.1A
rotein. Two sera showed reactivities with the ORF 73
rotein but not with the ORF 65 and K8.1A proteins. In
attern 4, there were no reactivities with HHV-8 proteins,
s seen with 3% (3 of 104) HIV1/KS2 sera, 26% (20 of 77)
IV1/KS2 sera, and 83% (70 of 84) of HIV2/KS2 sera
Figs. 1C and 3C, lanes 3 and 4).
In general, more sera recognized the ORF K8.1A protein
han the K8.1B protein (Table 1), indicating the presence of
dditional antigenic domains in the 61-aa stretch of ORF
8.1A protein that is spliced out in the ORF K8.1B protein
Chandran et al., 1998b). Because all the Western blot re-
ctions were stopped at the same time, the varying inten-
ity of bands detected probably reflected the titer of anti-
odies against the respective proteins. Many smaller-
olecular-weight recombinant proteins from bacteria (Fig.
) were also recognized by the sera and probably repre-
binant HHV-8 proteins and GST control expressed in the baculovirus
e insect cells were purified by glutathione–Sepharose columns. Equal
0% acrylamide gels and Western blotted. Prestained molecular weight
serum at a dilution of 1:100. (A) Reactivities of 4 different sera from
uals. (C) Reactivities of 4 different sera from HIV2/KS2 individuals. The
and with Recombinant HHV-8 Proteins in the Western Blot Assay
No. (%) positive by western blotb
ORF 73 ORF 65 K8.1A K8.1B
93 (89) 99 (95) 97 (93) 94 (90)
46 (60) 56 (73) 53 (69) 46 (60)
8 (10) 11 (13) 9 (11) 7 (8)
uced HHV-81 BCBL-1 cells and HHV-82 BJAB cells (Chandran et al.,
nd induced BCBL-1 cells (LANA) and cytoplasmic fluorescence with
ST and GST–HHV-8 proteins expressed in the insect cells from therecom
ed in th
un on 1
ies of 1
individABLE 1
ut TPA
)
)
)
TPA-ind
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386 ZHU ET AL.ented the breakdown products generated from the fusion
roteins. Sera also showed variable reactivities with the
reakdown products (Figs. 2C, lanes 3 and 4, and 2E, lane
), suggesting that different antigenic epitopes were recog-
ized. These smaller bands were minimal or absent in the
aculovirus recombinant proteins (Fig. 3), and no reactions
ere seen with the GST control protein.
omparison of reactivities of sera with HHV-8-
nfected BCBL-1 cells in IFA and with the
ecombinant HHV-8 proteins in Western
lot reactions
Sera from the HIV1/KS1 and HIV1/KS2 homosexual
dult male patients and from age-matched HIV2/KS2
T
Comparison of Reactivities of 104 HIV1/KS1 Sera from H
and in the Western Blot Assay w
2.1
LANA (IFA)
ORF 73 (WB)
Lytic (IFA)1 2
1 87 0 1
2 6 11 2
2.4
ORF 73 (WB)
ORF 65 (WB)
ORF 73 (WB)1 2
1 93 0 1
2 6 5 2
Note. These correlations in 2 3 2 tables are significant by x2 test. Lytic I
.3).
a The significance of changes is calculated by the McNemar chang
T
Comparison of Reactivities of 77 HIV1/KS2 Sera from H
and in the Western Blot Assay w
3.1
LANA (IFA)
ORF 73 (WB)
Lytic(IFA)1 2
1 43 0 1
2 3 31 2
3.4
ORF 73 (WB)
ORF 65 (WB)
ORF 73 (WB)1 2
1 46 0 1
2 10 21 2
Note. Lytic IFA vs ORF 65 WB, P 5 .025 (Table 3.2). Lytic IFA vs ORF
.6).
a These correlations in 2 3 2 tables are significant by x2 test.en were tested for HHV-8 antibodies by IFA with
ninduced and TPA-induced BCBL-1 (HHV-81) cells
Chandran et al., 1998a, 1998b). Specific granular
unctate nuclear fluorescence with the majority
.80%) of uninduced BCBL-1 cells and bright cytoplas-
ic fluorescence with ;30% of TPA-induced BCBl-1
ells were considered as recognizing latent and lytic
HV-8 antigens, respectively (Chandran et al., 1998a,
998b; Kedes et al., 1996; Lennette et al., 1996; Smith
t al., 1997). Although sera were tested with a starting
ilution of 1:10, several sera showed nonspecific flu-
rescence at 1:10 and 1:20 dilutions with BCBL-1 and
JAB cell. Hence, sera showing a reactivity at a dilu-
ion of $1:40 were considered positive.
xual Men in IFA with BCBL-1 Cells with or without TPA
Recombinant HHV-8 Proteins
2.3a
ORF 65 (WB)
Lytic (IFA)
K8.1A (WB)
1 2 1 2
99 4 1 97 6
0 1 2 0 1
2.6
K8.1A (WB)
ORF 65 (WB)
K8.1A (WB)
1 2 1 2
93 0 1 95 4
4 7 2 2 3
RF 65 WB, P 5 .025 (Table 2.2). Lytic IFA vs ORF K8.1A WB, P 5 .01 (Table
xual Men in IFA with BCBL-1 Cells with or without TPA
Recombinant HHV-8 Proteins
3.3a
ORF 65 (WB)
Lytic(IFA)
K8.1A (WB)
1 2 1 2
56 2 1 53 5
0 19 2 0 19
3.6a
K8.1A (WB)
ORF 65 (WB)
K8.1A (WB)
1 2 1 2
46 0 1 52 4
7 24 2 1 20
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387REACTIVITIES WITH HHV-8 ORFS 73, 65, K8.1A, AND K8.1B PROTEINSReactivities of HIV1/KS1 sera. The sera from HIV1/
S1 homosexual men reacted strongly with the unin-
uced and induced BCBL-1 cells. Of the 104 sera tested,
7 (84%) were positive for LANA-type fluorescence, and
heir titer ranged from 1:40 to 1:5120 (Tables 1 and 2). Of
his, 93 sera (89%) recognized the latency-associated
RF 73 protein in the Western blot reactions (Table 2.1),
nd 6 sera that were negative by LANA–IFA were posi-
ive in the Western blot reactions with the ORF 73 protein
Table 2.1). All sera positive for LANA-IFA were also
ositive for anti-ORF 73 antibodies, and thus the two
ssays gave concordant results (Table 2.1). One hundred
hree (99%) of these sera were positive for lytic type
luorescence, and their titer ranged from 1:40 to 1:20,480.
hese sera reacted strongly with the lytic cycle-associ-
ted ORF 65, K8.1A, and K8.1B proteins in the Western
lot reactions (95%, 93%, and 90%, respectively) (Table 1).
he IFA and the Western blot reactions showed concor-
ant results (Table 2). There were significant correlations
etween lytic–IFA reactivities and Western blot reactions
ith the ORF 65 protein (P 5 .025) or K8.1A protein (P 5
01), suggesting that testing sera with both ORF 65 and
8.1A proteins were equivalent in detecting anti-HHV-8
ytic antibodies.
All 93 (89%; 93 of 104) sera positive for antibodies
gainst the latency-associated ORF 73 protein were also
ositive in lytic–IFA (not shown) and for anti-ORF 65 and
K8.1A antibodies (Table 2). Because more sera recog-
ized the ORF K8.1A protein than the K8.1B protein (Table
), reactivities with the ORF K8.1A protein was examined
or further analysis. Of the 103 sera positive for lytic
ntibodies, 99 (95%) and 97(93%) were positive for ORF
5 and ORF K8.1A antibodies, respectively, in the West-
rn blot reactions. Overall, 95 (91%; 95 of 104) sera were
ositive by lytic–IFA as well as in Western blots for
ntibodies against ORFs 65 and K8.1A (Tables 2.2 and
.3). Of the 8 additional lytic–IFA-positive sera, 4 sera
ere also positive with the ORF 65 protein but not with
T
Comparison of Reactivities of 84 HIV2/KS2 Sera from
TPA and in Western Blot Assay
4.1
LANA (IFA)
ORF 73 (WB)
Lytic (IFA)1 2
1 7 0 1
2 1 76 2
4.4
ORF 73 (WB)
ORF 65 (WB)
ORF 73 (WB)1 2
1 6 2 1
2 5 71 2he ORF K8.1A protein, 2 sera were positive with the ORF
8.1A protein but not with the ORF 65 protein, and 2 sera
ere negative with both ORF 65 and K8.1A proteins
Tables 2.2 and 2.3). This suggested that the sera iden-
ified by lytic IFA were truly HHV-8 seropositive. When the
eactivities with the ORF 65 and K8.1A proteins were
onsidered together as a measure of HHV-8 seropositiv-
ty, 97% (101 of 104; 65 1 K8.1A) of HIV1/KS1 sera were
ositive with either antibody (Table 2.6), which is closely
imilar to the percentage (99%; 103 of 104) of sera pos-
tive for the lytic antibodies in IFA (Table 1). When the
eactivities with the ORF 73 protein together with either
nti-ORF 65 or -K8.1A reactivities were considered as a
easure of HHV-8 seropositivity, 95% (99 of 104; 73 1 65)
nd 93% (97 of 104; 73 1 K8.1A) of these sera were
ositive (Tables 2.4 and 2.5) .
Reactivities of HIV1/KS2 sera. Among the 77 HIV1/
S2 homosexual men sera examined, 56% (43 of 77) of
era were positive for LANA–IFA antibodies and 78% (58
f 77) were positive for lytic IFA antibodies (Table 1). The
iter ranged from 1:40 to 1:2560. Sixty percent (46 of 77)
f sera recognized the ORF 73 protein in the Western blot
eactions (Table 1). All sera positive by LANA–IFA were
lso positive for anti-ORF 73 antibodies and thus gave
oncordant results (Table 3.1). In the Western blot reac-
ions, 73%, 69%, and 60% of these sera recognized ORF
5, K8.1A, and K8.1B proteins, respectively (Table 1). Sera
egative for HHV-8 antibodies by lytic–IFA were also
egative in the Western blots with the ORF 73, 65, and
8.1A proteins (Tables 3.2 and 3.3). Only 2 sera positive
y lytic–IFA were negative for ORF 65 antibodies. In
ontrast, 5 sera positive by lytic–IFA were negative for
RF K8.1A antibodies (Tables 3.2 and 3.3). Similar to the
IV1/KS1 sera, 46 HIV1/KS2 sera positive for ORF 73
ntibodies in the Western blot reactions were also pos-
tive for ORFs 65 and K8.1A antibodies (Tables 3.4 and
.5). Four sera positive by lytic IFA antibodies and by ORF
5 reactivities did not react with the K8.1A protein, and 1
y Adult Men in IFA with BCBL-1 Cells with or without
e Recombinant HHV-8 Proteins
4.3
ORF 65 (WB)
Lytic (IFA)
K8.1A(WB)
1 2 1 2
10 0 1 9 1
1 73 2 0 74
4.6
K8.1A (WB)
ORF 65 (WB)
K8.1A (WB)
1 2 1 2
6 2 1 8 3
3 73 2 1 72ABLE 4
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388 ZHU ET AL.erum positive for K8.1A antibodies and by lytic–IFA was
egative for ORF 65 antibodies (Table 3.6). Seventy-four
ercent (57 of 77) of HIV1/KS2 sera were positive if the
eactivities with ORFs 65 and K8.1A proteins were con-
idered together as a measure of HHV-8 seropositivity
Table 3.6). When the reactivities with either ORF K8.1A or
5 proteins were considered together with the ORF 73
rotein reactivities, 69% (53 of 77; ORFs 73 1 8.1A) and
3% (56 of 77; ORFs 73 1 65) of these sera were positive
Tables 3.4 and 3.5).
Reactivities of HIV2/KS2 sera. We also tested 50 sera
rom children (ages 1–5), and these were negative by IFA
nd by the Western blot reactions (data not shown).
ighty-four sera from age-matched HIV2 healthy men
ere tested, and 35 sera were from blood bank donors
nd 49 sera were from men in the population. The sexual
rientation of these individuals is unknown. By IFA, only
% and 12% of these sera were positive for HHV-8 LANA
nd lytic antibodies, respectively, and the titers ranged
rom 1:40 to 1:320 (Table 1). Three (3 of 35; 9%) of the sera
ositive for lytic antibodies were from blood bank do-
ors, and 7 (7 of 49; 14%) were from the other adult male
roup. The reactivities of these sera with the ORF 73, 65,
8.1A, and K8.B proteins were 10%, 13%, 11%, and 8%,
espectively. Compared with the HIV1/KS1 and HIV1/
S2 sera, variable reactivities were seen in this group.
en percent (8 of 84) of sera recognized ORF 73 protein
n the Western blot reactions (Table 1). All sera positive
y LANA–IFA were also positive by the Western blot
eactions and gave concordant results (Table 4.1). How-
ver, 2 sera positive for ORF 73 antibodies in the Western
lot reactions were negative for lytic–IFA antibodies and
or the anti-ORF 65 and K8.1A antibodies (Tables 4.4 and
.5). One of these sera was positive by LANA-IFA, but the
ther 1 was negative. Except for 1 serum, sera negative
or HHV-8 antibodies by lytic–IFA were also negative on
he Western blot reactions with the ORF 65, K8.1A, and
8.1B proteins (Tables 4.2 and 4.3). One serum negative
or lytic–IFA was positive for ORF 65 antibodies, and 1
erum positive for lytic–IFA was negative for ORF K8.1A
ntibodies (Tables 4.2 and 4. 3). Three sera positive for
RF 65 antibodies did not react with the ORF K8.1A
rotein, and 1 serum positive for K8.1A antibodies was
egative with the ORF 65 protein (Table 4.6). Fourteen
ercent of these sera were positive if the reactivities with
he ORF 65 and K8.1A proteins were considered together
Table 4.6). When the reactivities with either ORF K8.1A or
5 proteins were considered together with the ORF 73
eactivities, 13% (11 of 84; ORFs 73 1 K8.1A) and 15% (13
f 84; ORFs 73 1 65) of these sera were considered
ositive (Tables 4.4 and 4.5).
DISCUSSION
With a DNA of ;160 kb, HHV-8 encodes .80 proteins
Neipel et al., 1997; Russo et al., 1996). Hence, it is logicalo anticipate that as in other herpesvirus infections, the
uman serological responses against HHV-8 would be
irected against a wide range of immunodominant as
ell as weak antigens representing a variety of HHV-8
roteins associated with the latent and lytic replicative
ycles. To compare the serological responses against
oth latent and lytic antigens of HHV-8, we selected
RFs 73, 65, K8.1A, and K8.1B because they were iden-
ified previously as immunogenic proteins (Chandran et
l., 1998a, 1998b; Lin et al., 1997; Rainbow et al., 1997;
abb et al., 1998; Simpson et al., 1996). Our studies
uggest that IFA with infected cells followed by the West-
rn blot reactions with a panel of latent and lytic immu-
ogenic antigens would provide a reliable, sensitive, and
pecific method for HHV-8 antibody detection.
The differential reactivities (Figs. 2 and 3) of each
erum with the recombinant HHV-8 proteins reflect the
ifferent titers of antibodies and suggested that serolog-
cal measurement of HHV-8 infection should not relay on
he use of 1 antigen alone. Both Rainbow et al. (1997) and
impson et al. (1996) used truncated proteins of ORFs 73
nd 65, respectively, and we used the full-length proteins
f ORFs 73, 65, K8.1A, and K8.1B. Our studies show that
esting sera with the ORF 73 protein appears to be more
ensitive than the use of LANA–IFA (Tables 1–4), and the
ull-length ORF 73 protein appears to detect more HHV-
-infected individuals (compared with data from the
tudy by Ranibow et al., 1997). The lytic–IFA recognized
lightly more HHV-8-seropositive individuals than the
estern blots with ORF 65 and K8.1A proteins (Table 1).
his could represent reactivities with other immunogenic
HV-8 proteins in IFA besides ORF 65 and K8.1A pro-
eins, with cross-reactive antibodies, or to the different
ilutions of sera used in these assays. The Western blot
ssays require ;4 ml of diluted sera to cover the mem-
ranes containing the transferred proteins. Due to the
imitation of the volume of sera available, we used a
:100 dilution of sera in the present study. To start the
nitial dilution of 1:10 for IFA testing, only ;10 ml of sera
as required, and only ;15 ml of each dilution was
equired to react with the fixed cells on the slides. How-
ver, our results showed a high degree of concordance
etween IFA and Western blot reactions. All HIV1/KS1
era and HIV1/KS2 sera reactive in lytic–IFA were also
ositive for latent antibodies. Except for 1 HIV2/KS2
erum, all sera positive by IFA with TPA-induced BCBL-1
ells were also positive for anti-ORFs 65 and K8.1A an-
ibodies, suggesting that the sera identified as positive
y lytic–IFA were truly HHV-8 seropositive.
IFAs using uninduced and TPA-induced BCBL-1 cells
re tedious and subjective. However, our studies show
hat IFA is specific for HHV-8 and detects a spectrum of
esponses against the various HHV-8 antigens. Compar-
sons of IFAs and Western blots detecting both latent and
ytic antibody responses suggest that this small panel of
ne latency-associated protein (ORF 73) and two lytic
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389REACTIVITIES WITH HHV-8 ORFS 73, 65, K8.1A, AND K8.1B PROTEINSycle-associated proteins (ORFs 65 and K8.1A) could
etect most of the human serological responses (Table
). Detection of a higher percentage of sera with lytic
HV-8 antibodies than with antibodies against the latent
ntigens by IFA (Table 1) may be due to the higher
umber of immunogenic proteins produced in a lytic
ycle than in a latent cycle, as well as the possible
ersistence of antibodies against lytic antigens. This
lso suggests that detection of LANA-type fluorescence
ay be specific yet may not be sensitive enough. Hence,
erological studies should include measurements of
oth latent and lytic antibodies, especially in countries
ike the United States, where HHV-8 is not as prevalent
s it is in Africa (Ariyoshi et al., 1998). However, to avoid
alse-positive reactivity at a lower dilution of sera, IFAs
hould be performed with dilutions of sera such as from
:10 to 1:160 rather than with one dilution (1:10) of sera
nly, as reported by Lennette et al. (1996).
All HIV1/KS1 and HIV1/KS2 sera positive for lytic
ntibodies were also positive for latent antibodies, and
o serum exhibiting only LANA-type fluorescence was
etected in this group (Tables 1 and 2). The trend was
lso closely similar in the HIV2/KS2 adult sera. However,
sera from HIV2/KS2 individuals were weakly positive
or ORF 73 antibodies only at a 1:100 dilution, but they
ere negative for lytic–IFA antibodies as well as for
ntibodies against ORFs 65 and K8.1A proteins in the
estern blot reactions (Tables 4.4 and 4.5). The reason
or the absence of lytic antibodies in these 2 sera is not
lear and could represent primarily a latent infection in
hese individuals as observed by Staskus et al. (1997).
imilarly, 1 HIV2/KS2 serum negative for lytic–IFA was
ositive for ORF 65 antibodies; the reason for this was
ot clear. Antibodies against EBV cross-reacting with
HV-8 ORF 65 protein appear not to be the reason
ecause this serum had a very low EBV titer (1:80) (data
ot shown). Other sera with high levels of EBV antibodies
Chandran et al., 1998; Smith et al., 1997) were negative
n both lytic HHV-8- IFA and Western blots with the ORF
5 protein. Another HIV2/KS2 serum positive by lytic–IFA
as negative for ORF K8.1A antibodies (Tables 4.2 and 4.
). These data also support our previous observations
Chandran et al., 1998a) that only very low levels of
ntibodies were present in the majority of HIV2/KS2
ndividuals and that these antibodies recognized only a
mall number of HHV-8 proteins. Hence, it is critical to
se both IFA and Western blot reactions to determine the
HV-8 seropositivity, especially in HIV2 asymptomatic
ndividuals. Sera with reactivities in at least two tests
hould be considered as positive.
Using a panel of sera, Rabkin et al. (1998) conducted a
linded comparison between the following assays: IFA
etecting antibodies against either the latency and the
ytic cycle-associated proteins, ELISA with truncated
RF 65 protein, ELISA with whole virus preparation, and
LISA with HHV-8 minor capsid ORF 26 protein. Thesessays frequently disagreed on individual sera, particu-
arly for blood donor samples. It was concluded that
hese assays are useful for epidemiological investiga-
ions and that the antibody detection technologies re-
uire further refinement to determine the precise preva-
ence of asymptomatic or cleared HHV-8 infection. These
ariations could be attributed to various factors such as
ntibody titers near the threshold of detection by these
ssays, relatively low antibody titers in HIV2 sera (Chan-
ran et al., 1998; Smith et al., 1997), different starting
ilutions used in the assays, or different methods to
stablish assay cutoffs for negative and positive results.
he variations observed by Rabkin et al. (1998) are ex-
ected because our studies show that the human sera
iffer in their abilities to recognize different HHV-8 pro-
eins, and the assays compared were measuring only
ne type of antibody response. Variations in our studies
ere evident only in the HIV2/KS2 adult sera from the
nited States. This group uniformly showed very low
HV-8 antibody titers; this could be due to the nature of
HV-8 pathogenesis in which only limited replications of
HV-8 occur in an immunocompetent individual and vi-
us reactivation occurs on reduction in the immune sur-
eillance. Our studies suggested that even in this group
f individuals, IFAs measuring both LANA and lytic anti-
odies, together with the Western blots with a panel of
HV-8 recombinant proteins, would confirm HHV-8 sero-
ositivity. A comparison of these sera with different as-
ays done in different laboratories must be carried out to
etermine the reliability of IFAs and the Western blot
ssays done in our laboratory. Studies are in progress to
etermine whether the measurement of antibodies
gainst these proteins would serve as a diagnostic
nd/or prognostic marker for KS and lymphoma devel-
pment and/or regression in HIV1 individuals.
MATERIALS AND METHODS
onstruction of recombinant plasmids
The cDNAs encoding HHV-8 ORFs K8.1A, K8.1B, and
5 were identified by screening a TPA-induced BCBL-1
DNA library in the lZAPII expression system with an
IV1/KS1 patient’s serum (Chandran et al., 1998a,
998b). The identified cDNAs were released into the
hagemid forms by in vivo excision using the ExAssist
elper phage. The full-length cDNAs encoding HHV-8
RFs K8.1A, K8.1B, and 65 were amplified by PCR with
he following primers: K8.1A/B, 59-CGGGGATCCATGAGT-
CCACACAGATTCGC-39/59-ATGGTCTCGAGTTACACTAT-
TAGGGTTTC-39; and ORF 65, 59-CTGAGGCTATTTG-
ATCCCCTGTGTGGAAG-39/59-TGGTACTTGTGACTC-
AGGGTTGTCCAATCG-39. The full-length genomic ORF
3 from the BCBL-1 cell DNA was amplified by PCR with
he following primers: ORF 73, 59-GTTGTCAGACCA-
AATTCCCGAGGATGGCG-39/59-GCCAAATGCAAGT-
CGCGGCCGCGACGGTGGCTTCTA-39. The restriction
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390 ZHU ET AL.ites in the primers used for cloning purposes are un-
erlined. Amplified PCR fragments were purified and
igated into pGEM-T vector (Promega). Orientation was
erified by restriction enzyme digestion. Full-length ORFs
ere verified by sequence analysis and by in vitro tran-
cription and translation (Chandran et al., 1998a, 1998b).
xpression of HHV-8 ORFs 73, K8.1A, K8.1B, and 65 in
he bacterial expression vector
The plasmids in the pGEM-T vectors were digested
ith the appropriate enzymes and subcloned into the
ST expression vector pGEX-4T-1 (Pharmacia). Expres-
ion and purification of the 4 HHV-8 recombinant pro-
eins were performed as described previously (Chandran
t al., 1998bb). Briefly, 50 ml of overnight culture was
dded into 450 ml of LB with 100 mg/ml ampicillin. After
1-h incubation at 37°C, expression was induced with
.2 mM isopropyl-b-D-thiogalactoside for 3 h. The Esch-
richia coli cells were pelleted and resuspended in 10 ml
f NETN (0.5% Nonidet P-40, 1 mM EDTA, 20 mM Tris–
Cl, pH 8.0, and 100 mM NaCl) buffer containing 1% (v/v)
f a bacterial protease inhibitor cocktail (Sigma Chemi-
al, St. Louis, MO). The cells were lysed by sonication on
ce and centrifuged at 12,000g for 15 min at 4°C. The
usion proteins were purified by glutathione–Sepharose
B (Pharmacia) according to the manufacturer’s recom-
endations.
xpression of recombinant HHV-8 proteins in the
aculovirus-insect cell system
A baculovirus GST expression and purification kit was
sed to prepare recombinant HHV-8 proteins (Pharmin-
en). The full-length cDNAs of ORFs K8.1A, K8.1B, 65, and
enomic 73 were amplified by PCR with the following
rimers: K8.1A/B, 59-TTCCGCGTGAGCTCATGAGTTCCA-
ACAGA-39/59-GGCCGGGTACCTTACACTATGTAGG-39;
RF 65, 59-GGCTATTTGAGCTCCCTGTGTGGAAGATGT-
9/59-TGGTACTTGTGAGGTACCGGTTGTCCAATCG-39;
nd ORF 73, 59-GTTGTCAGACCAGAATTCCCGAGGATG-
CG-39/59-GCCAAATGCAAGTGCGCGGCCGCGACG-
TGGCTTCTA-39. The restriction sites in the primers
sed for cloning purposes are underlined. The PCR prod-
cts of ORFs K8.1A, K8.1B, and 65 were cloned into the
acI and KpnI sites of the pAcGHLT-A baculovirus trans-
er vector. The PCR-amplified ORF 73 was inserted into
he EcoRI and NotI sites of the pAcGHLT-A vector. Ori-
ntation was verified by restriction enzyme digestion. To
enerate recombinant baculovirus, all of the four recom-
inant plasmid pAcGHLT-As were cotransfected with
aculogold DNA (PharMingen) into Sf9 cells. Recombi-
ant virus that was obtained was passaged three times
efore use. Expression and purification of fusion proteins
ere done according to the manufacturer’s recommen-
ations (PharMingen).estern blot assays
Randomly grouped and coded sera were tested in the
estern blot reactions by three different individuals. The
esults were read and recorded separately. Glutathione
olumn-purified HHV-8 ORF K8.1A, K8.1B, 65, and 73
usion proteins and GST control (;100 ng/well) were
eparated by 10% SDS–PAGE and electrophoretically
ransferred onto nitrocellulose membranes. Standard
restained molecular weight markers (GIBCO BRL) were
ncluded in parallel lanes. The membranes were soaked
n blocking solution (10 mM Tris–HCl, pH 7.2, 150 mM
aCl, 5% skim milk, 0.02% NaN3) at 4°C overnight and
hen reacted with human sera diluted to 1:100 in blocking
olution for 3 h at room temperature. The membranes
ere washed three times with washing buffer (10 mM
ris–HCl, pH 7.2, 150 mM NaCl, 0.3% Tween 20) and
ncubated for 1 h with alkaline phosphatase (AP)-conju-
ated goat anti-human IgG (KPL, Gaithersburg, MD).
ound, enzyme-labeled antibodies were detected by
olor reaction of AP with nitroblue tetrazolium and 5-bro-
o-4-chloro-3-indolyphosphate substrate (Sigma Chem-
cal). The reactions were stopped at the same time for all
he blots by washing the membranes in distilled water.
ell lines
HHV-81 and EBV2 BCBL-1 (a gift from Dr. McGrath,
niversity of California, Los Angeles) (Renne et al., 1996)
nd HHV-82/EBV2 BJAB cells were grown in RPMI 1640
edium with glutaMAX I (GIBCO BRL) supplemented
ith 10% heat-inactivated FBS and antibiotics.
erum samples
Sera from HIV1/KS1 and HIV1/KS2 homosexual adult
ale patients (ages 18–50 years) and age-matched
IV2/KS2 men were used in these studies (Chandran et
l., 1998a, 1998b). All sera were stored at 220°C and
eat inactivated at 56°C for 30 min before use.
FAs
IFAs were performed as described previously (Chan-
ran et al., 1998a, 1998b), and coded sera were tested by
wo individuals and read by one individual. Briefly, 107
ells in 10 ml of medium were induced with 20 ng/ml TPA
Sigma Chemical). Uninduced and TPA-induced BCBL-1
nd BJAB cells were collected, washed in PBS, pH 7.4,
potted onto slides (5-mm inner diameter, 10 circles per
lide), air dried in laminar flow hood under UV light, and
ixed in cold acetone for 10 min. Fixed cells were incu-
ated for 30 min at 37°C with 2-fold dilutions of human
era beginning at 1:10 to 1:160. After incubation, slides
ere washed rigorously in PBS. All sera were tested
sing two methods to detect the bound human antibod-
es. In one method, the slides were incubated for 30 min
t 37°C with a prestandardized dilution of fluorescein
i
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391REACTIVITIES WITH HHV-8 ORFS 73, 65, K8.1A, AND K8.1B PROTEINSsothiocyanate (FITC)-conjugated goat anti-human IgG
Hyclone, Logan, UT). After washing, the slides were
ounter stained with 1:10,000 dilution of Evans’ blue
Sigma Chemical) for 5 min at room temperature,
ashed, and mounted with 50% (vol/vol) glycerol in PBS.
he other method is described by Lennette et al. (1996);
lides were incubated for 30 min at 37°C with a pre-
tandardized dilution of an anti-human monoclonal anti-
ody followed by FITC-labeled anti-mouse antibodies
nd Evans’ blue counterstain. Slides were examined un-
er a fluorescence microscope. Both detection methods
ave similar results and titer of sera. Sera showing these
pecific reactivities at $1:40 dilutions were considered
s positive, and sera with positive reactivity at 1:160
ilution were further tested from 1:160 to 1:20,480.
tatistical analyses
Data were analyzed with the help of Dr. Khatab Has-
anein (Department of Biometry, The University of Kan-
as Medical Center). The significance of changes was
alculated by the McNemar change test and by the x2
est.
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